You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cytarabine-based chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 23, 2022

Thrombocytopenia, Cytarabine Causing Adverse Effects in Therapeutic Use, Lymphoma Trial in Guangzhou (avatrombopag)

Not yet recruiting
  • Thrombocytopenia
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 11, 2021

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)

Not yet recruiting
  • Secondary Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Mar 22, 2023

Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Sep 18, 2023

Acute Myeloid Leukemia Trial in United States (Cytarabine, Idarubicin, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +6 more
Nov 16, 2022

Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)

Not yet recruiting
  • Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
  • (no location specified)
Feb 27, 2023

Acute Lymphoblastic Leukemia, ALL, Childhood, ALL Trial in Chicago (Ruxolitinib, Cyclophosphamide, Cytarabine)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
    University of Chicago Medical Center
Sep 14, 2021

Supportive Care, Childhood Cancer Trial in Copenhagen (parent-led home-administered low-dose Cytarabine)

Recruiting
  • Supportive Care
  • Childhood Cancer
  • parent-led home-administered low-dose Cytarabine
  • Copenhagen, Danmark, Denmark
    Louise Ingerslev Roug
May 10, 2022

Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 21, 2023

Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU de Nantes
Jan 24, 2023

Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
May 18, 2022

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Allogeneic HCT
  • Consolidation chemotherapy
  • Charlotte, North Carolina
    Levine Cancer Institute
Apr 19, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

Suspended
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Los Angeles, California
  • +5 more
Dec 10, 2022

Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU of Nantes
Dec 16, 2022

Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Venetoclax Oral Tablet
  • +2 more
  • Bronx, New York
    Montefiore Einstein Cancer Center
Jul 14, 2022

NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
  • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
  • Tianjing, Tianjin, China
    Tianjin cancer hospital
Nov 3, 2023

Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
  • +1 more
Oct 7, 2022

Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

Not yet recruiting
  • Leukemia, Acute Myeloid (AML)
  • (no location specified)
Oct 16, 2022

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Dec 13, 2022

Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

Recruiting
  • Myeloid Malignancies
  • fractionated busulfan-based conditioning regimen
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Mar 29, 2023

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of

Not yet recruiting
  • Organoids
  • +2 more
  • Biopsy
  • (no location specified)
Nov 24, 2023

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023